Multiple Myeloma In General and NCT03605719 SpecificallyA poster elsewhere mentioned MM results, and I cannot find them.
I was prompted to look up the above noted MM trial. It added the CPI Opdivo - BMS. It is worth noting that this trial added the CPI to a combo that was already said to have been very promising. It is also worth noting that the Actual Completion Date was October 2022, as compared to the Anticipated date of May 2024. In my limited experience those dates are usually reveresed; that is to say actual date is after the anticipated date. This was a Phase 1 trial.
Another note of interest; it is possible but highly unlikely to receive Accelerated Approval off a Phase 1 trial. I am in no way suggesting that that factoid applies to the above.
Three Questions.
1. What MM trial was the other poster referring to?
2. If not the above trial, where are the results for it?
and most importantly
3. Is there an effort at Head Office to package and present all the goods ONC/Y has to offer?